FDA Warning Letter — Halosense Inc.

Case 606153 — FEI 3016610659

The FDA took a Warning Letter action against Halosense Inc. on Mar 30, 2020 (London, Canada). The action was issued by CDER and concerns drugs products.

Action details

Facility
Halosense Inc.
Date
Mar 30, 2020
Fiscal Year
2020
Product Type
Drugs
Center
CDER
Location
London (Canada)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.